BEONE MEDICINES LTD-ADR (ONC) Stock Income Statement
NASDAQ:ONC - US07725L1026 - ADR
341.8 USD
+23.07 (+7.24%)
341.8 USD
0 (0%)
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 29.90B | 27.21B | 17.42B | 9.57B | 7.59B | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | N/A | |||
| Cost Of Goods | 4.59B | 4.26B | 2.71B | 1.90B | 1.06B | |||
| Gross Profit | 25.31B | 22.95B | 14.71B | 7.66B | 6.53B | |||
| Operating Expenses | 27.56B | 27.19B | 23.46B | 19.69B | 16.00B | |||
| Research and Development | 14.29B | 13.55B | 12.45B | 10.83B | 9.19B | |||
| Selling, General, and Administrative Expenses | 13.38B | 13.25B | 10.86B | 8.77B | 6.59B | |||
| Operating Income | -2.24B | -4.24B | -8.75B | -12.03B | -9.47B | |||
| Interest Income/Expense | 59.20M | 44.52M | -59.34M | -1.40B | -109.94M | |||
| Other Income/Expense | -490.00K | -654.00K | 2.60B | -1.76M | 19.00K | |||
| Non Recurring Items | 3.05M | 35.11M | -248.00K | -295.00K | -685.00K | |||
| Income Before Taxes | -2.18B | -4.16B | -6.21B | -13.43B | -9.58B | |||
| Income Tax | 982.57M | 815.64M | 507.59M | 215.08M | 168.19M | |||
| Net Income | -3.16B | -4.98B | -6.72B | -13.64B | -9.75B | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -26.16 | -41.34 | -56.21 | -115.61 | -82.93 | |||
| Non GAAP EPS | 255.46 | -41.34 | -52.67 | -115.61 | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 84.66% | 84.33% | 84.45% | 80.10% | 86.02% | |||
| Profit Margin | -10.58% | -18.29% | -38.55% | -142.60% | -128.45% | |||
| Operating Profit Margin | -7.50% | -15.59% | -50.22% | -125.71% | -124.77% | |||
All data in CNY